Talaromyces marneffei Infection Misdiagnosed as Lung Cancer and Retrospective Literature Analysis
Authors:
Open Access
- 1 February 2026
- journal article
- case report
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-10
Abstract
Background: Talaromyces marneffei (TM), an opportunistic fungal pathogen, causes severe infections in immunocompromised individuals. While endemic to tropical regions of Southeast Asia and South Asia, sporadic cases have been reported in non-endemic areas. Diagnosis is often delayed due to nonspecific clinical and laboratory features, contributing to high mortality. Case Presentation: A HIV-positive patient subsequently developed TM pulmonary infection. Clinical symptoms and laboratory test results were non-specific. Imaging studies revealed pulmonary masses, and the patient was misdiagnosed with lung cancer outside the hospital, leading to an erroneous surgical resection. The patient did not improve postoperatively but instead developed high fever and persistent cough, with symptoms worsening. During treatment at our hospital, the patient was definitively diagnosed with TM lung infection, not lung cancer. Due to the rarity of TM infection and lack of experience, treatment was delayed, leading to worsening of the patient’s condition. The patient exhibited gastrointestinal bleeding, progressive neurological dysfunction, hydrocephalus, and multi-organ dysfunction, which ultimately resulted in the death of the patient. Conclusion: TM infections often present with insidious onset, prolonged course, and lack of specific clinical symptoms, imaging findings, or laboratory test characteristics, making diagnosis challenging and frequently leading to misdiagnosis or missed diagnosis, resulting in high mortality rates. Therefore, clinicians should enhance their diagnostic and treatment experience regarding TM infections in HIV-positive individuals or populations in non-endemic regions, initiate pathogen culture and histopathological diagnosis as early as possible, and integrate the results of mNGS and mass spectrometry analysis to improve the detection rate and early diagnosis rate of TM infections. This will ensure that patients can receive timely and accurate treatment, which is crucial for improving their prognosis.Keywords
This publication has 22 references indexed in Scilit:
- An Overlooked and Underrated Endemic Mycosis—Talaromycosis and the Pathogenic Fungus Talaromyces marneffeiClinical Microbiology Reviews, 2023
- Rapid diagnosis of Talaromyces marneffei infection by metagenomic next-generation sequencing technology in a Chinese cohort of inborn errors of immunityFrontiers in Cellular and Infection Microbiology, 2022
- CT findings of Talaromyces marneffei infection among HIV patients with lymphadenopathyFrontiers in Medicine, 2022
- Rare misdiagnosed case of penicilliosis marneffei in an immunocompetent patientJournal of International Medical Research, 2020
- A 52-Year-Old Man With an 11-Month History of Fever, Cough, Chest Pain, Pleural Effusion, and Left Lung AtelectasisChest, 2020
- Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort studyClinical Microbiology and Infection, 2019
- Fungal infections in HIV/AIDSThe Lancet Infectious Diseases, 2017
- A Trial of Itraconazole or Amphotericin B for HIV-Associated TalaromycosisNew England Journal of Medicine, 2017
- Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet NamClinical Infectious Diseases, 2011
- Penicillium marneffeiInfection and Recent Advances in the Epidemiology and Molecular Biology AspectsClinical Microbiology Reviews, 2006